[HTML][HTML] Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infections

CM Perry, A Markham - Drugs, 1999 - Springer
Piperacillin/tazobactam is a β-lactam/β-lactamase inhibitor combination with a broad
spectrum of antibacterial activity encompassing most Gram-positive and Gram-negative …

Deep space neck infection: principles of surgical management

TM Osborn, LA Assael, RB Bell - Oral and maxillofacial surgery clinics of …, 2008 - Elsevier
Knowledge of the management of infections of the deep spaces of the neck is essential to
the daily practice of oral and maxillofacial surgery. Timely decisions must be made through …

Contemporary management of deep neck space infections

PW Gidley, BY Ghorayeb… - … —Head and Neck …, 1997 - journals.sagepub.com
Deep neck infections continue to be seen despite the wide use of antibiotics. These
infections follow along fascial planes to create deep neck space abscesses. The clinical …

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis

C Jaccard, N Troillet, S Harbarth, G Zanetti… - Antimicrobial agents …, 1998 - Am Soc Microbiol
Nosocomial pneumonia and acute peritonitis may be caused by a wide array of pathogens,
and combination therapy is often recommended. We have previously shown that imipenem …

[HTML][HTML] Combined application of bacterial predation and violacein to kill polymicrobial pathogenic communities

H Im, SY Choi, S Son, RJ Mitchell - Scientific Reports, 2017 - nature.com
Violacein is a bisindole antibiotic that is effective against Gram-positive bacteria while the
bacterial predator, Bdellovibrio bacteriovorus HD100, predates on Gram-negative strains. In …

Synergistic antimicrobial metal oxide-doped phosphate glasses; a potential strategy to reduce antimicrobial resistance and host cell toxicity

FNS Raja, T Worthington, LPL de Souza… - ACS Biomaterials …, 2022 - ACS Publications
The emergence of antimicrobial resistant strains bacteria and a decline in the discovery of
new antibiotics has led to the idea of combining various antimicrobials to treat resistant …

[HTML][HTML] Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 β-lactamase: insights into the mechanism of inhibition

D Sulton, D Pagan-Rodriguez, X Zhou, Y Liu… - Journal of Biological …, 2005 - ASBMB
Clavulanic acid is a potent mechanism-based inhibitor of TEM-1 and SHV-1β-lactamases,
enzymesthatconferresistancetoβ-lactamsinmany Gram-negative pathogens. This compound …

[HTML][HTML] The Pharmaco –, Population and Evolutionary Dynamics of Multi-drug Therapy: Experiments with S. aureus and E. coli and Computer Simulations

P Ankomah, PJT Johnson, BR Levin - PLoS Pathogens, 2013 - journals.plos.org
There are both pharmacodynamic and evolutionary reasons to use multiple rather than
single antibiotics to treat bacterial infections; in combination antibiotics can be more effective …

[HTML][HTML] Understanding resistance to β-lactams and β-lactamase inhibitors in the SHV β-lactamase: lessons from the mutagenesis of SER-130

MS Helfand, CR Bethel, AM Hujer, KM Hujer… - Journal of Biological …, 2003 - ASBMB
Bacterial resistance to β-lactam/β-lactamase inhibitor combinations by single amino acid
mutations in class A β-lactamases threatens our most potent clinical antibiotics. In TEM-1 …

Piperacillin/tazobactam versus cefotaxime plus metronidazole for treatment of children with intra-abdominal infections requiring surgery

H Maltezou, P Nikolaidis, E Lebesii, L Dimitriou… - European Journal of …, 2001 - Springer
The efficacy of piperacillin/tazobactam at 100/12.5 mg/kg every 8 h (35 patients) was
compared to cefotaxime plus metronidazole at 50/7.5 mg/kg every 8 h (35 patients) in 70 …